StonvexLoading…
StonvexStonvexStonvexCore line items from RKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.70B | $5.10B | $3.80B | $5.84B |
Operating Income | $-214.00M | $668.00M | $-403.00M | $741.91M |
Net Income | $-68.00M | $29.00M | $-16.00M | $46.42M |
EPS (Diluted) | $-0.05 | $0.21 | $-0.15 | $0.28 |
Total Assets | $60.69B | $24.51B | $19.23B | $20.08B |
Total Liabilities | $37.79B | $15.47B | $10.93B | $11.61B |
Cash & Equivalents | $2.70B | $1.27B | $1.11B | $722.29M |
Free Cash Flow OCF − CapEx | $-4.02B | $-2.70B | $51.00M | $10.73B |
Shares Outstanding | 1.32B | 141.04M | 1.98B | 1.97B |